LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 213 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,162,842 | +18.8% | 136,229 | +43.0% | 0.01% | +25.0% |
| Q2 2023 | $6,869,040 | -3.2% | 95,271 | -1.3% | 0.00% | 0.0% |
| Q1 2023 | $7,098,688 | +110.3% | 96,502 | +91.0% | 0.00% | +100.0% |
| Q4 2022 | $3,375,204 | -19.4% | 50,527 | +3.9% | 0.00% | -33.3% |
| Q3 2022 | $4,186,000 | -6.3% | 48,608 | -2.9% | 0.00% | +50.0% |
| Q2 2022 | $4,466,000 | -22.0% | 50,059 | -1.7% | 0.00% | -33.3% |
| Q1 2022 | $5,727,000 | -48.1% | 50,904 | -28.8% | 0.00% | -40.0% |
| Q4 2021 | $11,036,000 | +27.8% | 71,454 | +15.3% | 0.01% | +25.0% |
| Q3 2021 | $8,632,000 | -12.4% | 61,960 | -17.5% | 0.00% | -20.0% |
| Q2 2021 | $9,852,000 | -22.0% | 75,098 | -9.4% | 0.01% | -28.6% |
| Q1 2021 | $12,636,000 | +49.3% | 82,885 | -2.6% | 0.01% | +40.0% |
| Q4 2020 | $8,461,000 | +5.5% | 85,073 | +1.1% | 0.01% | -16.7% |
| Q3 2020 | $8,017,000 | -29.7% | 84,114 | -17.6% | 0.01% | -33.3% |
| Q2 2020 | $11,412,000 | +63.5% | 102,024 | +6.3% | 0.01% | +50.0% |
| Q1 2020 | $6,979,000 | -13.5% | 95,975 | +24.1% | 0.01% | +20.0% |
| Q4 2019 | $8,066,000 | +35.7% | 77,353 | +29.5% | 0.01% | +25.0% |
| Q3 2019 | $5,946,000 | +6.0% | 59,751 | +21.5% | 0.00% | +33.3% |
| Q2 2019 | $5,608,000 | -29.3% | 49,160 | -22.1% | 0.00% | -40.0% |
| Q1 2019 | $7,933,000 | -55.5% | 63,135 | -52.0% | 0.01% | -61.5% |
| Q4 2018 | $17,834,000 | -76.4% | 131,438 | -52.3% | 0.01% | -40.9% |
| Q3 2018 | $75,642,000 | -57.4% | 275,573 | -67.8% | 0.02% | -56.9% |
| Q2 2018 | $177,555,000 | +155.0% | 857,065 | +103.3% | 0.05% | +54.5% |
| Q1 2018 | $69,633,000 | +7.9% | 421,633 | -10.6% | 0.03% | -19.5% |
| Q4 2017 | $64,549,000 | -7.7% | 471,423 | -8.2% | 0.04% | -14.6% |
| Q3 2017 | $69,930,000 | +0.9% | 513,641 | -10.1% | 0.05% | -2.0% |
| Q2 2017 | $69,326,000 | +12.9% | 571,067 | -1.6% | 0.05% | +8.9% |
| Q1 2017 | $61,397,000 | +18.7% | 580,117 | +14.0% | 0.04% | +7.1% |
| Q4 2016 | $51,704,000 | +8.4% | 508,870 | +8.9% | 0.04% | +23.5% |
| Q3 2016 | $47,698,000 | -9.9% | 467,378 | +5.2% | 0.03% | -8.1% |
| Q2 2016 | $52,966,000 | +9.6% | 444,098 | -1.6% | 0.04% | +2.8% |
| Q1 2016 | $48,334,000 | +13.9% | 451,355 | +15.3% | 0.04% | +24.1% |
| Q4 2015 | $42,451,000 | +25.3% | 391,562 | -1.0% | 0.03% | +11.5% |
| Q3 2015 | $33,876,000 | +7.6% | 395,558 | +26.8% | 0.03% | +30.0% |
| Q2 2015 | $31,480,000 | +30.1% | 312,021 | -0.6% | 0.02% | +33.3% |
| Q1 2015 | $24,191,000 | +38.3% | 313,747 | -4.6% | 0.02% | +36.4% |
| Q4 2014 | $17,497,000 | +3.2% | 328,866 | -8.8% | 0.01% | 0.0% |
| Q3 2014 | $16,947,000 | +215.7% | 360,677 | +318.4% | 0.01% | +175.0% |
| Q2 2014 | $5,368,000 | +21.3% | 86,199 | +31.1% | 0.00% | +33.3% |
| Q1 2014 | $4,424,000 | -32.4% | 65,770 | -47.1% | 0.00% | -40.0% |
| Q4 2013 | $6,542,000 | -64.0% | 124,422 | -70.4% | 0.01% | -61.5% |
| Q3 2013 | $18,158,000 | – | 419,645 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |